MétaCan
Menu
Back to cohort
Record W2140014443 · doi:10.1200/jco.2014.60.3845

Cisplatin and Etoposide Versus Carboplatin and Paclitaxel With Concurrent Radiation for Stage III Non–Small-Cell Lung Cancer: Is There an Impact on Radiation Pneumonitis Rates?

2015· letter· en· W2140014443 on OpenAlexaff
David A. Palma, Suresh Senan, George Rodrigues

Bibliographic record

VenueJournal of Clinical Oncology · 2015
Typeletter
Languageen
FieldMedicine
TopicLung Cancer Research Studies
Canadian institutionsLondon Health Sciences Centre
Fundersnot available
KeywordsMedicineCarboplatinInternal medicineOncologyEtoposideChemoradiotherapyLung cancerRadiation therapyVeterans AffairsMucositisPneumonitisSurgeryCisplatinChemotherapyLung

Abstract

fetched live from OpenAlex

The article by Santana-Davila et al 1 compared etoposide and cisplatin (EP) with carboplatin and paclitaxel (CP) when delivered as part of concurrent chemoradiotherapy (CCRT) for stage III non-small-cell lung cancer (NSCLC).By using the Veterans' Affairs (VA) Central Cancer Registry, the authors conducted a robust comparison of overall survival (OS) with EP versus CP, using a Cox proportional hazards model, propensity score techniques, and instrumental variable analysis.OS outcomes were not different between the two regimens, but EP was associated with higher rates of complications, including hospitalization, infection, acute renal disease/dehydration, and mucositis/esophagitis.The authors correctly point out that the findings are in contradistinction to a phase II randomized controlled trial 2 (RCT) that had suggested superior OS with EP compared with CP.A potential concern with the use of CP as part of CCRT for stage III NSCLC has been the risk of radiation pneumonitis (RP).RP can adversely affect quality of life, and can uncommonly lead to long-term oxygen dependence or death.Taxanes are potent radiosensitizers, and an individual patient data meta-analysis identified CP use as a major risk factor for RP, with an odds ratio of 5.52 of developing symptomatic RP with CP compared with EP. 3 The risk was highest in elderly patients (age 65 years) who received CP; such patients had an RP risk greater than 50%.Similarly, in the RCT noted above, the RP rate was 48.5% in the CP arm and 25% in the EP arm (P .09). 2 In their study, Santana-Davila et al 1 used International Classification of Diseases, 9th revision, codes to identify toxicities within the VA database but did not include RP (International Classification of Diseases, 9th revision, code 508.0) as one of the outcomes assessed.A comparison of RP rates with CP versus EP within the VA database would help to address this concern regarding pulmonary toxicity.The pathogenesis and risk of RP may differ depending on ethnicity, 4 analogous to the increased risk of hematologic toxicity demonstrated in Asian versus non-Asian patients receiving CCRT for NSCLC. 5The meta-analysis and RCT contained many Asian patients, whereas the VA database contains mostly white male patients 1 ; therefore, the high risk of RP associated with CP in the two former studies may not generalize to the VA population.Could the authors provide additional data analysis comparing RP rates between the CP and EP groups in their study?

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.001
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow), Research integrity
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.239
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0020.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0020.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0010.003
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.151
GPT teacher head0.525
Teacher spread0.375 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designNot applicable
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations4
Published2015
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Clinical OncologySame topicLung Cancer Research StudiesFrench-language works237,207